Primary gleason grade 4 at the positive margin is associated with metastasis and death among patients with gleason 7 prostate cancer undergoing radical prostatectomy

European Urology

Volumn 66, Issue 6, 2014, Pages 1116-1124

  Viers, Boyd R ^a   Sukov, William R ^b   Gettman, Matthew T ^a   Rangel, Laureano J ^b   Bergstralh, Eric J ^b   Frank, Igor ^a   Tollefson, Matthew K ^a   Thompson, R Houston ^a   Boorjian, Stephen A ^a   Karnes, R Jeffrey ^a  

^a DEPARTMENT OF UROLOGY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cancer mortality; Gleason score 7; Positive surgical margin; Prostate cancer; Radical prostatectomy; Systemic progression

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; ONCOLOGICAL PARAMETERS; POSITIVE SURGICAL MARGIN; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; SENSITIVITY ANALYSIS; TUMOR VOLUME; BLOOD; CANCER GRADING; DISEASE FREE SURVIVAL; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; PATHOLOGY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 84909962503     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.07.004     Document Type: Article

References (30)

1. P. Swindle, J.A. Eastham, and M. Ohori Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 174 2005 903 907
2. M.L. Blute, E.J. Bergstralh, A. Iocca, B. Scherer, and H. Zincke Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy J Urol 165 2001 119 125
3. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012
4. S.J. Kausik, M.L. Blute, and T.J. Sebo Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy Cancer 95 2002 1215 1219
5. S.A. Boorjian, R.J. Karnes, and P.L. Crispen The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era J Urol 183 2010 1003 1009
6. M.A. Simon, S. Kim, and M.S. Soloway Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins J Urol 175 2006 140 144 discussion 144-5
7. J.L. Wright, B.L. Dalkin, and L.D. True Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality J Urol 183 2010 2213 2218
8. A.J. Stephenson, D.P. Wood, and M.W. Kattan Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy J Urol 182 2009 1357 1363
9. K. Udo, A.M. Cronin, and L.J. Carlino Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade J Urol 189 2013 1302 1307
10. S.A. Boorjian, M.K. Tollefson, L.J. Rangel, E.J. Bergstralh, and R.J. Karnes Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy Prostate Cancer Prostatic Dis 15 2012 56 62
11. S.A. Boorjian, R.H. Thompson, and M.K. Tollefson Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence Eur Urol 59 2011 893 899
12. J. Pfitzenmaier, S. Pahernik, T. Tremmel, A. Haferkamp, S. Buse, and M. Hohenfellner Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int 102 2008 1413 1418
13. H.J. Chalfin, M. Dinizo, and B.J. Trock Impact of surgical margin status on prostate-cancer-specific mortality BJU Int 110 2012 1684 1689
14. A.J. Stephenson, S.E. Eggener, and A.V. Hernandez Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality Eur Urol 65 2014 675 680
15. P.A. Fontenot, and A.M. Mansour Reporting positive surgical margins after radical prostatectomy: time for standardization BJU Int 111 2013 E290 E299
16. D. Cao, A.S. Kibel, F. Gao, Y. Tao, and P.A. Humphrey The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence Am J Surg Pathol 34 2010 994 1001
17. R. Savdie, L.G. Horvath, and R.P. Benito High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy BJU Int 109 2012 1794 1800
18. J.G. Huang, J. Pedersen, and M.K. Hong Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer BJU Int 111 2013 921 927
19. F. Brimo, A.W. Partin, and J.I. Epstein Tumor grade at margins of resection in radical prostatectomy specimens is an independent predictor of prognosis Urology 76 2010 1206 1209
20. D.G. Bostwick, R.P. Myers, and J.E. Oesterling Staging of prostate cancer Semin Surg Oncol 10 1994 60 72
21. J.A. Wieder, and M.S. Soloway Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer J Urol 160 1998 299 315
22. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474
23. A.J. Stephenson, M.W. Kattan, and J.A. Eastham Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition J Clin Oncol 24 2006 3973 3978
24. M.R. Cooperberg, J.F. Hilton, and P.R. Carroll The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy Cancer 117 2011 5039 5046
25. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis J Natl Cancer Inst 101 2009 878 887
26. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
27. E.W. Steyerberg, and M.J. Pencina Reclassification calculations for persons with incomplete follow-up Ann Intern Med 152 2010 195 196 author reply 196-7
28. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
29. I.M. Thompson, R.K. Valicenti, and P. Albertsen Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline J Urol 190 2013 441 449
30. M.K. Tollefson, B.C. Leibovich, J.M. Slezak, H. Zincke, and M.L. Blute Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival J Urol 175 2006 547 551